The new chemotherapy is effective against both pediatric and adult cancers, and it allows other chemotherapies to more readily reach their targets.
How should we talk to patients and their families about these sensitive subjects?
While people with sickle cell disease have better outcomes in the United States and other Western countries, progress in treating the disease has been slow moving.
An emerging, innovative metric could radically change childhood health policy.
Adolescents and young adults with cancer have unique needs that may explain their plateau in survival rates, despite improved survival rates in other age groups.
A recent decision may define the future of virotherapy’s role in the clinical treatment of cancer.
